Hikal Ltd share price logo

Hikal Share Price

NSE: HIKAL

BSE: 524735

Small Cap

Healthcare Sector

₹219.20

-5.78

(-2.57%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Hikal Stock Performance

as on November 24, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹218
    ₹225.79
    downward going graph

    0.55%

    Downside

    3.01%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹218
    ₹464.75
    downward going graph

    0.55%

    Downside

    112.02%

    Upside

    downward going graph

Hikal share price movements today

Previous Close
₹224.98
Open
₹225.00
Volume
2.81L
Upper Circuit
₹269.97
Lower Circuit
₹179.98
Day's Low - High
₹218 - ₹225.79
52 Week Low - High
₹218 - ₹464.75

Hikal Historical Returns

1 Month Return
-7.42 %
3 Month Return
-12.36 %
1 Year Return
-43.15 %
3 Year Return
-32.96 %
5 Year Return
+ 29.9 %

Hikal Fundamentals

as on November 24, 2025 at 4:01 pm IST

Market Cap

₹2,774.02 Cr

Return on Equity (ROE)

7.42

PE Ratio (TTM)

277.75

Return on capital employed (ROCE)

9.49

Industry PE ratio

41.99

Beta (LTM)

0.87

P/B Ratio

3.91

Dividend Yield

0.2

PEG Ratio

-53.93

Quarterly Earnings Growth YOY

-290.71

EPS (TTM)

7.35

Sector

Pharmaceuticals

Book Value

102.21

Technical Analysis

Bearish

View Technical Analysis

Hikal Stock Valuation

as on November 24, 2025 at 4:01 pm IST

Hikal in the last 5 years

  • Overview

  • Trends

Lowest (8.33x)

March 24, 2020

Industry (41.99x)

November 21, 2025

Today (277.75x)

November 21, 2025

Highest (314.81x)

October 1, 2025

LowHigh

Today’s Price to Earnings Ratio: 277.75x

Hikal Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hikal with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Hikal Ltd image
Hikal Ltd
BUY2,774.025.98%0.70901,859
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY22,544.6811.75%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY16,850.7513.44%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,413.82-4.87%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY13,507.3739.08%0.672441,515
See all

Analyst Recommendation on Hikal Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Hikal. Average target price of ₹320

Source: S&P Global Market Intelligence

Hikal Share Price Target

Get share price movements and forecasts by analysts on Hikal.

What analysts predicted

42.23%UPSIDE

Target Price

₹320

Current Price

₹219.2

Analyzed by

1 Analysts

High

₹320

Target

₹320.00

Low

₹320

Hikal target price ₹320, a slight upside of 42.23% compared to current price of ₹219.2. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Hikal Stock’s Investor Sentiment and Interest

Search interest for Hikal Ltd Stock has increased by 31% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:31% versus previous 30 day period

Hikal Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
538.45
537.9
386.1
431.23
438.5
512.8
403.8
450.8
438.9
550
371.3
316.2
Other Income
2.51
0.38
0.9
0.99
0.1
0.5
0.5
0.4
3.6
0.5
1
1.9
Total Income
542.71
545.67
388.9
435.87
447.6
514.6
407.3
453.3
451.3
552.9
381.4
320.4
Expenses
465.62
457.28
337.7
377.36
382.8
419.7
348.8
378
375.6
429
355.3
311.3
Operating Profit
72.83
80.62
48.4
53.87
55.7
93.1
55
72.8
63.3
121
16
4.9
Operating Profit Margin %
13.53%
14.99%
12.54%
12.49%
12.7%
18.16%
13.62%
16.15%
14.42%
22%
4.31%
1.55%
Profit Before Interest, Tax and Depreciation
77.09
88.39
51.2
58.51
64.8
94.9
58.5
75.3
75.7
123.9
26.1
9.1
Interest
13.03
12.98
13.8
13.08
14.2
15.3
19.8
18.8
18.7
17.9
17.1
14.9
Depreciation
28.27
26.83
27.7
28.57
29
32.3
31.8
31.7
33.2
37.7
39.4
41.2
Profit Before Tax
35.79
48.58
9.7
16.86
21.6
47.3
6.9
24.8
23.8
68.3
-30.4
-47
Tax Paid
9.38
12.58
2.8
4.29
5.5
13.4
1.8
6.5
6.6
18.1
-8
-12.1
Profit After Tax
26.41
36
6.9
12.57
16.1
33.9
5.1
18.3
17.2
50.2
-22.4
-34.9
Total Net profit including share of profit / Loss from associate company
26.41
36
6.9
12.57
16.1
33.9
5.1
18.3
17.2
50.2
-22.4
-34.9
EPS
2.14
2.92
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
Actual EPS
2.14
2.92
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
Adjusted EPS
2.14
2.92
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83
Diluted EPS
2.14
2.92
0.56
1.02
1.31
2.76
0.41
1.48
1.39
4.07
-1.82
-2.83

Hikal Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,000.29
1,278.35
1,567.74
1,462.12
1,707.06
1,926.03
2,004.7
1,768.7
1,843.5
Other Income
3.44
4.46
2.26
3.7
4.98
4.89
5.41
2.5
5
Total Income
1,017.38
1,300.56
1,591.87
1,510.96
1,725.42
1,947.61
2,028.44
1,787.1
1,864.8
Expenses
819.63
1,054.35
1,291.49
1,249.51
1,397.55
1,602.16
1,765.96
1,517.6
1,531.4
Operating Profit
180.66
224
276.25
212.61
309.51
323.87
238.74
251.1
312.1
Operating Profit Margin %
18.06%
17.52%
17.62%
14.54%
18.13%
16.82%
11.91%
14.2%
16.93%
Profit Before Interest, Tax and Depreciation
197.75
246.21
300.38
261.45
327.87
345.45
262.48
269.5
333.4
Interest
48.29
49.12
58.43
52.42
36.2
31.21
48.1
56.4
75.2
Depreciation
69.14
85.59
92.88
82.46
85.24
95.67
109.01
117.6
134.4
Profit Before Tax
80.32
111.5
149.07
126.57
206.43
218.57
105.37
95.5
123.8
Tax Paid
12.55
34.27
46.01
42.14
73.28
58.06
26.98
25.9
33
Profit After Tax
67.77
77.23
103.06
84.43
133.15
160.51
78.39
69.6
90.8
Total Net profit including share of profit / Loss from associate company
67.77
77.23
103.06
84.43
133.15
160.51
78.39
69.6
90.8
EPS
8.2
9.4
8.36
6.85
10.8
13.02
6.36
5.64
7.36
Actual EPS
8.2
9.4
8.36
6.85
10.8
13.02
6.36
5.64
7.36
Adjusted EPS
5.47
6.27
8.36
6.85
10.8
13.02
6.36
5.64
7.36
Diluted EPS
8.2
9.4
8.36
6.85
10.8
13.02
6.36
5.64
7.36

Hikal Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
185.61
163.48
138.81
185.59
284.93
229.02
293.73
315.31
186.7
280.4
Cash Flow from Investing Activities
-63.91
-102.17
-110.12
-124.59
-163.79
-156.2
-284.37
-292.33
-173.7
-136.5
Cash Flow from Financing Activities
-123.63
-63.28
-24.79
-55.41
-100.87
-96.87
-5.56
-7.68
-27
-143.6
Net Cash Flow
-1.93
-1.96
3.9
5.59
20.27
-24.05
3.8
15.29
-14
0.3

Hikal Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
68.83%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
68.85%
DII
1.57%
2.19%
2.78%
3.12%
3.15%
3.53%
3.17%
3.58%
3.48%
3.8%
4.02%
5.16%
FII
0%
0%
0%
4.81%
6.13%
6.55%
6.67%
6.78%
6.06%
5.69%
5.36%
4.23%
Public
25.21%
24.4%
23.8%
23.22%
21.86%
21.07%
21.32%
20.79%
21.61%
21.66%
21.77%
21.76%
Total Outstanding Shares
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
12,33,00,750
Total Shareholders
75,780
75,167
75,110
76,126
74,657
71,840
70,978
71,912
71,801
68,907
71,391
73,404

Hikal Corporate Actions

View detailed summary of the earnings and dividend history of Hikal.

  • Hikal Ltd Earnings Results

    Hikal Ltd’s net profit fell -290.71% since last year same period to ₹-34.90Cr in the Q2 2025-2026. On a quarterly growth basis, Hikal Ltd has generated -55.8% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Hikal Ltd Dividends May,2025

    In the quarter ending March 2025, Hikal Ltd has declared dividend of ₹0.80 per share on 14 May 2025 - translating a dividend yield of 0.62%.

    Read More about Dividends

Indices Featuring Hikal Stock

Check stock indices that include Hikal.

BSE Healthcare

₹44,202.14

-0.44 (▲-193.52%)

BSE Small-Cap

₹51,579.23

-0.83 (▲-432.43%)

Insights on Hikal Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.97% to 4.09% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 128.4% return, outperforming this stock by 161.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.85% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 12.9% return, outperforming this stock by 56.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 552.9 Cr → 320.4 Cr (in ₹), with an average decrease of 23.5% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, HIKAL stock has moved down by -40.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.77% to 21.76% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 50.2 Cr → -34.9 Cr (in ₹), with an average decrease of 100.2% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 5.36% to 4.23% in Sep 2025 quarter

About Hikal Ltd

Hikal Limited is an Indian-based company, incorporated in 1988, with global recognition in the pharmaceutical, crop protection, animal health, biocides and specialty chemicals industries. It has 5 manufacturing facilities in 3 states, producing various chemical intermediates, active pharma ingredients, APIs and contract research activities. With their multiple partnerships and technological expansion projects, they have achieved milestones such as receiving the 5 Star Safety Award from the UK British Safety Council and their promotion to a trading house status. They have acquired an agrochemical manufacturing site from Novartis India Limited, which was followed by an investment in a JV with a Sinochem Corporation China subsidiary. Furthermore, they provide human and animal health products, amongst others. Recent developments such as the long-term contracts with life science companies, the sale of the RD unit and the bonus share issuance to shareholders indicate the company's success.

Revenue: ₹316.20Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-34.90Cr as on September 2025 (Q2 FY26)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
OrganisationHikal Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOJai Hiremath
E-voting on sharesClick here to vote

FAQs

What is Hikal share price today?

Hikal share price today stands at ₹219.2 as on at the close of the market. Hikal share today touched a day high of ₹225.79 and a low of ₹218.

What is the 52 week high and 52 week low range for Hikal share?

Hikal touched a 52 week high of ₹464.75 and a 52 week low of ₹218. Hikal share price today i.e. is closed at ₹219.2, which is -52.83% down from its 52 week high and 0.55% up from its 52 week low.

What is Hikal's market capitalisation today?

Hikal market capitalisation is ₹2,774.02 Cr as on .

How to buy Hikal shares?

To buy Hikal shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for HIKAL or Hikal Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Hikal shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Hikal trading volume today?

Hikal trading volume is 2.81L as on . This means that 2.81L shares of Hikal were bought and sold on the stock market during today's trading session.